Profilomic (Health Division) is Biotechnology in France that focus on lipidomic analysis business. Founded in 2010. They cover business area such as Provider, metabolic and lipidomic analysis service, identification, biomarker, diagnosis, disease, therapeutic efficacy, tissue, cell, biological fluid, expertise, experimental toxicology, drug metabolism, fibroblast, blood-brain barrier, quantitative method.
2010
( 14 years old in 2024 )
Lipidomic Analysis
-
31 rue d'Aguesseau
92100 Boulogne-Billancourt
France
Private
Providermetabolic and lipidomic analysis serviceidentificationbiomarkerdiagnosisdiseasetherapeutic efficacytissuecellbiological fluidexpertiseexperimental toxicologydrug metabolismfibroblastblood-brain barrierquantitative method
* We use standard office opening hours in near Profilomic (Health Division)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Profilomic (Health Division) is Biotechnology business from France that founded in 2010 (14 years old in 2024), Profilomic (Health Division) business is focusing on Lipidomic Analysis.
Profilomic (Health Division) headquarter office and corporate office address is located in 31 rue d'Aguesseau 92100 Boulogne-Billancourt France.
Profilomic (Health Division) was founded in France.
In 2024, Profilomic (Health Division) is currently focus on lipidomic analysis sector.
Above is snippet of Google Trends for "lipidomic analysis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Profilomic (Health Division), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
